CN109432023A - A kind of ibuprofen arginine tablet and preparation method thereof - Google Patents

A kind of ibuprofen arginine tablet and preparation method thereof Download PDF

Info

Publication number
CN109432023A
CN109432023A CN201811567394.3A CN201811567394A CN109432023A CN 109432023 A CN109432023 A CN 109432023A CN 201811567394 A CN201811567394 A CN 201811567394A CN 109432023 A CN109432023 A CN 109432023A
Authority
CN
China
Prior art keywords
ibuprofen
arginine
brufen
preparation
ibuprofen arginine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811567394.3A
Other languages
Chinese (zh)
Inventor
傅兆瑞
朱永香
孙婷婷
蒋克安
马婷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui Dongsheng International Pharmaceutical Co Ltd
Original Assignee
Anhui Dongsheng International Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui Dongsheng International Pharmaceutical Co Ltd filed Critical Anhui Dongsheng International Pharmaceutical Co Ltd
Priority to CN201811567394.3A priority Critical patent/CN109432023A/en
Publication of CN109432023A publication Critical patent/CN109432023A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention discloses a kind of ibuprofen arginine tablets and preparation method thereof, ibuprofen arginine microparticle is prepared using centrifugal granulating method, and processing is coated by capsule core of ibuprofen arginine microparticle, the shortcomings that overcoming the ibuprofen arginine easy moisture absorption covers the penetrating odor of drug itself;Using silica auxiliary acrylic resin pharmaceutical carrier as coating material, brufen coated granule is prepared, the dissolution of brufen is accelerated, the bitter taste of brufen can be covered;Using the ibuprofen granule powder after coating as tabletting powder in the present invention, cooperate softwood processed with auxiliary material, tablet is prepared through granulation, tabletting again, compared with the process of the prior art, the ibuprofen arginine tablet of the method for the present invention preparation has dissolution rate high, the advantages that stability is good, and bioavilability is high, is not easy the moisture absorption.

Description

A kind of ibuprofen arginine tablet and preparation method thereof
Technical field
The invention belongs to technical field of medicine, and in particular to a kind of ibuprofen arginine tablet and preparation method thereof.
Background technique
Brufen is that clinically common Nonsteroidal anti-inflammatory, antalgesic, analgesic activity are significant.Brufen is practically insoluble in Water, the pharmacokinetic parameters Tmax value (time for reaching maximum plasma concentration) of tablet are 1.5-2 hours, are worked relatively slow. Ibuprofen arginine is brufen soluble derivative, and it is water soluble quick-acting that the dosage form of report, which has syrup and granule, Preparation increases body absorption rate.But although syrup and granule can reach quick-acting, the problem is that acrid flavour is peppery, disease People's poor resistance.
Onset time, T are shortened compared with Genpril by tablet made of raw material of arginine IbuprofenmaxValue is 0.5 hour.Due to not being aqueous solution compared with arginine Ibuprofen syrup and granule, so there is no pungent sense when medication, Increase the tolerance of patient.In addition, arginine ibuprofen tablet production, storage and patient carry, take than arginine cloth Ibuprofen syrup and granule are convenient, and additive of tablet and preparation packaging are also simply inexpensive compared with other preparations.
But according to the prior art, it is very difficult that ibuprofen arginine is made into solid pharmaceutical preparation, especially be made granule and When tablet, one side moisture absorption phenomenon is very serious, on the other hand makes to be made into specific dosage form due to irritating smell and is limited System.
Hot-melt extruded (Hot Melt Extrusion, HME) technology is the extrusion by single screw rod or twin-screw, by raw material Medicine, carrier material mix simultaneously, melt molding, and due to its strong mixing and shear action, drug and carrier material are by multiphase State switchs to single phase, is present in drug in carrier material with molecular state.
Summary of the invention
In view of the above shortcomings of the prior art, the purpose of the present invention is to provide a kind of ibuprofen arginine tablet and systems Preparation Method, the ibuprofen arginine tablet being prepared are not easy the moisture absorption, effectively improve the solubility of brufen, improve curative effect, together When can cover the bitter taste of brufen, increase the tolerance of patient.
In order to achieve the above objectives, the invention adopts the following technical scheme:
A kind of ibuprofen arginine tablet prepares ibuprofen arginine microparticle using centrifugal granulating method, and with cloth Lip river Fragrant arginine microparticle is capsule core, using silica auxiliary acrylic resin pharmaceutical carrier as coating material, prepares brufen packet Clothing particle, then formed through soft material granulation, tabletting;
The partial size of the ibuprofen arginine microparticle is in 0.25~0.45mm.
Further, the ibuprofen arginine tablet mixes system with auxiliary material using brufen coated granule as tabletting powder It is prepared at softwood, then through granulation, tabletting;The auxiliary material includes one of adhesive, disintegrating agent, lubricant or a variety of mixed It closes.
Further, the disintegrating agent is selected from low-substituted hydroxypropyl cellulose, microcrystalline cellulose, crospovidone, crosslinking One of sodium carboxymethylcellulose is a variety of.
Further, the lubricant is selected from one of stearic acid, superfine silica gel powder, talcum powder or a variety of.
The invention also discloses the preparation methods of above-mentioned ibuprofen arginine tablet, including following preparation step:
(1) granulation capsule core: being placed in centrifugation pellet processing machine for suitable arginine Ibuprofen, be then turned on centrifugation pellet processing machine, And -80% ethanol of 0.5% PVP K30 is sprayed, centrifugal granulator is carried out, by the arginine Ibuprofen capsule core prepared at 40 DEG C At a temperature of be dried, and sieved with 40 mesh, 60 mesh screens, it is micro- to the arginine Ibuprofen between 60 mesh to collect 40 mesh Ball, as capsule core;
(2) preparation of brufen coated granule:
Using silica, acrylic resin pharmaceutical carrier as coating material, pelletize through hot-melt extruded;
Brufen bulk pharmaceutical chemicals and coating material being taken, with 1:(1.2-1.5) ratio of (ω/ω) is uniformly mixed, with step (1) Arginine Ibuprofen capsule core after mixing, is added in the loading hopper of hot-melt extruded instrument, and preheating heats mini-extruder extrusion instrument extremely before feeding Set temperature is 80-85 DEG C, sets screw speed as 30-60r/min;
Fusant is squeezed out after squeezing out by head die hole with form of strips, is cooled to room temperature, and is crushed, and brufen coating is obtained Particle;
(3) softwood is prepared:
The brufen coated granule for taking step (2) to prepare is uniformly mixed with disintegrating agent, adds adhesive softwood;
(4) granulation, tabletting:
Softwood obtained by step (3) is pelletized, 16 meshes are crossed, and crosses 14 mesh whole grains after drying, by particle after whole grain with Lubricant is added in mixing machine, and tabletting is after mixing to get the ibuprofen arginine tablet.
Further, the mass ratio of ibuprofen arginine capsule core and coating material is in the brufen coated granule (1.5-2): 1.
Further, the mass ratio in the coating material between silica and acrylic resin pharmaceutical carrier is 1: (3-5)。
The present invention has the beneficial effect that:
(1) present invention prepares ibuprofen arginine microparticle using centrifugal granulating method, and with ibuprofen arginine micro- Grain is the shortcomings that capsule core is coated processing, overcomes the ibuprofen arginine easy moisture absorption, the penetrating odor of cover drug itself.
(2) using silica auxiliary acrylic resin pharmaceutical carrier as coating material, brufen coated granule, a side are prepared Face silica has porous structure and polymolecularity, has extremely strong adsorption capacity to drug, so that brufen is easily adsorbed to Inside, while the silicone hydroxyl (- SiOH) of particle surface has very strong affinity to water, and can with there are the ends such as-OH ,-NH The molecule of group forms intermolecular hydrogen bonding and accelerates brufen so as to improve the mobility of brufen coated granule powder Dissolution;Anionic group in another aspect ibuprofen molecule and the cation group in acrylic resin pharmaceutical carrier molecule with Hydrogenbond can cover the bitter taste of brufen.
(3) processing of Genpril is mostly using brufen/arginine Ibuprofen bulk pharmaceutical chemicals and auxiliary material in the prior art Mixing is coated processing after granulation, tabletting again, and using the ibuprofen granule powder after coating as tabletting in the present invention Powder cooperates softwood processed with auxiliary material, then prepares tablet through granulation, tabletting, compared with the process of the prior art, this hair The ibuprofen arginine tablet of bright method preparation has dissolution rate high, and stability is good, and bioavilability is high, and it is excellent to be not easy moisture absorption etc. Point.
Specific embodiment
The present invention is further explained with reference to embodiments, but is not intended to limit the contents of the present invention.
A kind of specific embodiment: preparation method of ibuprofen arginine tablet, the specific steps are as follows:
(1) granulation capsule core: being placed in centrifugation pellet processing machine for suitable arginine Ibuprofen, be then turned on centrifugation pellet processing machine, And -80% ethanol of 0.5% PVP K30 is sprayed, centrifugal granulator is carried out, by the arginine Ibuprofen capsule core prepared at 40 DEG C At a temperature of be dried, and sieved with 40 mesh, 60 mesh screens, it is micro- to the arginine Ibuprofen between 60 mesh to collect 40 mesh Ball, as capsule core;
(2) preparation of brufen coated granule:
Using silica, acrylic resin pharmaceutical carrier as coating material, pelletize through hot-melt extruded;The silica with Mass ratio between acrylic resin pharmaceutical carrier is 1:(3-5);
Brufen bulk pharmaceutical chemicals and coating material being taken, with 1:(1.2-1.5) ratio of (ω/ω) is uniformly mixed, with step (1) Arginine Ibuprofen capsule core after mixing, is added in the loading hopper of hot-melt extruded instrument, and preheating heats mini-extruder extrusion instrument extremely before feeding Set temperature is 80-85 DEG C, sets screw speed as 30-60r/min;By head die hole with form of strips after fusant extrusion It squeezes out, is cooled to room temperature, crush, obtain brufen coated granule;
The mass ratio of ibuprofen arginine capsule core and coating material is (1.5-2) in the brufen coated granule: 1.
(3) softwood is prepared:
The brufen coated granule for taking step (2) to prepare is uniformly mixed with disintegrating agent, adds adhesive softwood;It is described Disintegrating agent is selected from one of low-substituted hydroxypropyl cellulose, microcrystalline cellulose, crospovidone, croscarmellose sodium Or it is a variety of;
(4) granulation, tabletting:
Softwood obtained by step (3) is pelletized, 16 meshes are crossed, and crosses 14 mesh whole grains after drying, by particle after whole grain with Lubricant is added in mixing machine, and the lubricant is selected from one of stearic acid, superfine silica gel powder, talcum powder or a variety of;Mixing is equal Tabletting is after even to get the ibuprofen arginine tablet.
Embodiment 1:
The preparation of every 1000 arginine ibuprofen tablets, the specific steps are as follows:
(1) granulation capsule core: weighing 200g arginine Ibuprofen and be placed in centrifugation pellet processing machine, be then turned on centrifugation pellet processing machine, And -80% ethanol of 0.5% PVP K30 is sprayed, centrifugal granulator is carried out, by the arginine Ibuprofen capsule core prepared at 40 DEG C At a temperature of be dried, and sieved with 40 mesh, 60 mesh screens, it is micro- to the arginine Ibuprofen between 60 mesh to collect 40 mesh Ball, as capsule core;
(2) preparation of brufen coated granule:
25g silica, 75g acrylic resin pharmaceutical carrier are weighed as coating material, is pelletized through hot-melt extruded;
It weighs 130g brufen bulk pharmaceutical chemicals and coating material is uniformly mixed, then is mixed with step (1) arginine Ibuprofen capsule core It after closing uniformly, is added in the loading hopper of hot-melt extruded instrument, preheating hot melt mini-extruder extrusion instrument to set temperature is 82 DEG C before feeding, setting Screw speed is 35r/min;Fusant is squeezed out after squeezing out by head die hole with form of strips, is cooled to room temperature, and is crushed, is obtained Brufen coated granule;
(3) softwood is prepared:
Brufen coated granule and 12g low-substituted hydroxypropyl cellulose, the 28g microcrystalline cellulose for taking step (2) to prepare are mixed It closes uniformly, rotating speed of agitator 24 turns/min, mixing time 30min, 150g cornstarch is added by several times in material upon mixing Slurry, and 40min is stirred in timing, and softwood is made;
(4) granulation, tabletting:
Softwood obtained by step (3) is pelletized, crosses 16 meshes, and under the conditions of 50 DEG C of ± 5 DEG C of temperature, dry 25 ± 5min crosses 14 mesh whole grains after dry, and particle detections moisture must not cross 3.0% after whole grain;
Particle after whole grain and 28g lubricant talcum powder are added in mixing machine, tabletting is after mixing to get the cloth Lip river Fragrant arginine tablets.
Embodiment 2:
The preparation of every 1000 arginine ibuprofen tablets, the specific steps are as follows:
(1) granulation capsule core: weighing 200g arginine Ibuprofen and be placed in centrifugation pellet processing machine, be then turned on centrifugation pellet processing machine, And -80% ethanol of 0.5% PVP K30 is sprayed, centrifugal granulator is carried out, by the arginine Ibuprofen capsule core prepared at 40 DEG C At a temperature of be dried, and sieved with 40 mesh, 60 mesh screens, it is micro- to the arginine Ibuprofen between 60 mesh to collect 40 mesh Ball, as capsule core;
(2) preparation of brufen coated granule:
25g silica, 75g acrylic resin pharmaceutical carrier are weighed as coating material, is pelletized through hot-melt extruded;
It weighs 130g brufen bulk pharmaceutical chemicals and coating material is uniformly mixed, then is mixed with step (1) arginine Ibuprofen capsule core It after closing uniformly, is added in the loading hopper of hot-melt extruded instrument, preheating hot melt mini-extruder extrusion instrument to set temperature is 82 DEG C before feeding, setting Screw speed is 35r/min;Fusant is squeezed out after squeezing out by head die hole with form of strips, is cooled to room temperature, and is crushed, is obtained Brufen coated granule;
(3) softwood is prepared:
The brufen coated granule for taking step (2) to prepare is uniformly mixed with 18g crospovidone, 23g microcrystalline cellulose, is stirred Mix 24 turns/min of paddle revolving speed, 150g corn starch liquid, and timing is added in material upon mixing in mixing time 30min by several times 40min is stirred, softwood is made;
(4) granulation, tabletting:
Softwood obtained by step (3) is pelletized, crosses 16 meshes, and under the conditions of 50 DEG C of ± 5 DEG C of temperature, dry 25 ± 5min crosses 14 mesh whole grains after dry, and particle detections moisture must not cross 3.0% after whole grain;
Particle after whole grain and 16g stearic acid, 24g superfine silica gel powder are added in mixing machine, tabletting is after mixing to get institute State ibuprofen arginine tablet.
Embodiment 3:
The preparation of every 1000 arginine ibuprofen tablets, the specific steps are as follows:
(1) granulation capsule core: weighing 200g arginine Ibuprofen and be placed in centrifugation pellet processing machine, be then turned on centrifugation pellet processing machine, And -80% ethanol of 0.5% PVP K30 is sprayed, centrifugal granulator is carried out, by the arginine Ibuprofen capsule core prepared at 40 DEG C At a temperature of be dried, and sieved with 40 mesh, 60 mesh screens, it is micro- to the arginine Ibuprofen between 60 mesh to collect 40 mesh Ball, as capsule core;
(2) softwood is directly prepared:
25g silica, 75g acrylic resin pharmaceutical carrier are weighed, then weighs 130g brufen bulk pharmaceutical chemicals and is uniformly mixed, It is uniformly mixed again with step (1) arginine Ibuprofen capsule core, obtains mixing medicine, for use;
Mixing medicine is taken to be uniformly mixed with 12g low-substituted hydroxypropyl cellulose, 28g microcrystalline cellulose, 24 turns of rotating speed of agitator/ 150g corn starch liquid is added in material upon mixing by several times by min, mixing time 30min, and 40min is stirred in timing, is made Softwood;
(3) granulation, tabletting:
Softwood obtained by step (2) is pelletized, crosses 16 meshes, and under the conditions of 50 DEG C of ± 5 DEG C of temperature, dry 25 ± 5min crosses 14 mesh whole grains after dry, and particle detections moisture must not cross 3.0% after whole grain;
Particle after whole grain and 28g lubricant talcum powder are added in mixing machine, tabletting is after mixing to get the cloth Lip river Fragrant arginine tablets.
Embodiment 4: testing result
By embodiment 1-3, arginine Ibuprofen piece obtained presses Chinese Pharmacopoeia two annex progress quality of version in 2010 respectively It examines, specific examination table 1.
Disintegration time refers to the ifs vitro disintegration time, specifically using 37 DEG C of water as medium, when investigating the ifs vitro disintegration of oral disintegrating tablet Between.
Porosity test: in Example 1-3 gained tablet horizontalization ware, 5 are placed under the conditions of room temperature relative humidity is 80% It, and compared in the investigation of sampling in 3,5 days.
1 testing result of table
Without Cotton seeds in embodiment 3, used coating material directly with brufen bulk pharmaceutical chemicals, brufen essence ammonia Sour pellet directly mixes softwood processed, is processed into tablet, as shown in table 1, the arginine ibuprofen tablet and reality of embodiment 1-2 preparation The tablet for applying the preparation of example 3 is compared, and is not easy suction and is shown, moisture protection is obvious preferably.

Claims (7)

1. a kind of ibuprofen arginine tablet, which is characterized in that ibuprofen arginine microparticle is prepared using centrifugal granulating method, And using ibuprofen arginine microparticle as capsule core, using silica auxiliary acrylic resin pharmaceutical carrier as coating material, preparation Brufen coated granule, then formed through soft material granulation, tabletting;
The partial size of the ibuprofen arginine microparticle is in 0.25~0.45mm.
2. a kind of ibuprofen arginine tablet according to claim 1, which is characterized in that the ibuprofen arginine tablet Using brufen coated granule as tabletting powder, it is mixed and made into softwood with auxiliary material, then be prepared through granulation, tabletting;The auxiliary material Including one of adhesive, disintegrating agent, lubricant or a variety of mixing.
3. a kind of ibuprofen arginine tablet according to claim 2, which is characterized in that the disintegrating agent is selected from low substitution One of hydroxypropyl cellulose, microcrystalline cellulose, crospovidone, croscarmellose sodium are a variety of.
4. a kind of ibuprofen arginine tablet according to claim 2, which is characterized in that the lubricant is selected from tristearin One of acid, superfine silica gel powder, talcum powder are a variety of.
5. a kind of preparation method of the ibuprofen arginine tablet as described in claim 1-4 is any, which is characterized in that including as follows Preparation step:
(1) granulation capsule core: suitable arginine Ibuprofen is placed in centrifugation pellet processing machine, is then turned on centrifugation pellet processing machine, and spray - 80% ethanol of 0.5% PVP K30 is spilt, centrifugal granulator is carried out, by the arginine Ibuprofen capsule core prepared in 40 DEG C of temperature Under be dried, and sieved with 40 mesh, 60 mesh screens, collect 40 mesh to the arginine Ibuprofen pellet between 60 mesh, make For capsule core;
(2) preparation of brufen coated granule:
Using silica, acrylic resin pharmaceutical carrier as coating material, pelletize through hot-melt extruded;
Brufen bulk pharmaceutical chemicals and coating material being taken, with 1:(1.2-1.5) ratio of (ω/ω) is uniformly mixed, with the smart ammonia of step (1) Ibuprofen acid capsule core after mixing, is added in the loading hopper of hot-melt extruded instrument, and preheating hot melt mini-extruder extrusion instrument is extremely set before feeding Temperature is 80-85 DEG C, sets screw speed as 30-60r/min;
Fusant is squeezed out after squeezing out by head die hole with form of strips, is cooled to room temperature, and is crushed, and brufen coating is obtained Grain;
(3) softwood is prepared:
The brufen coated granule for taking step (2) to prepare is uniformly mixed with disintegrating agent, adds adhesive softwood;
(4) granulation, tabletting:
Softwood obtained by step (3) is pelletized, 16 meshes are crossed, and crosses 14 mesh whole grains after drying, by particle after whole grain and lubrication Agent is added in mixing machine, and tabletting is after mixing to get the ibuprofen arginine tablet.
6. a kind of preparation method of ibuprofen arginine tablet according to claim 5, which is characterized in that the brufen The mass ratio of ibuprofen arginine capsule core and coating material is (1.5-2) in coated granule: 1.
7. a kind of preparation method of ibuprofen arginine tablet according to claim 5, which is characterized in that the coating material Mass ratio in material between silica and acrylic resin pharmaceutical carrier is 1:(3-5).
CN201811567394.3A 2018-12-21 2018-12-21 A kind of ibuprofen arginine tablet and preparation method thereof Pending CN109432023A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811567394.3A CN109432023A (en) 2018-12-21 2018-12-21 A kind of ibuprofen arginine tablet and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811567394.3A CN109432023A (en) 2018-12-21 2018-12-21 A kind of ibuprofen arginine tablet and preparation method thereof

Publications (1)

Publication Number Publication Date
CN109432023A true CN109432023A (en) 2019-03-08

Family

ID=65560449

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811567394.3A Pending CN109432023A (en) 2018-12-21 2018-12-21 A kind of ibuprofen arginine tablet and preparation method thereof

Country Status (1)

Country Link
CN (1) CN109432023A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1528278A (en) * 2003-10-15 2004-09-15 杭州容立医药科技有限公司 Method for preparing composition granules containing ibuprofen amino guanidyl valeric acid

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1528278A (en) * 2003-10-15 2004-09-15 杭州容立医药科技有限公司 Method for preparing composition granules containing ibuprofen amino guanidyl valeric acid

Similar Documents

Publication Publication Date Title
CN102579381B (en) Guanidine hydrochloride sustained release preparation and preparation method thereof
JPS6191118A (en) Granule of thiamine salt, its production, and tablet
JP2016539955A (en) Drug composition, method for producing the same, and use
CN103830184A (en) Solid dispersion system of febuxostat and preparation method of solid dispersion system, and pharmaceutical applications
CN109925290B (en) Theophylline sustained release tablet and preparation process thereof
CN104352441A (en) DMF (dimethyl fumarate) enteric-coated micropellet and preparation method thereof
CN109512792A (en) A kind of process of the Genpril of granulation production twice
CN103263395A (en) Telmisartan tablet preparation and preparation method thereof
CN103610658A (en) Immunomodulator slow-release preparation and preparation method thereof
CN108236605A (en) A kind of pharmaceutical composition of prednisone acetate tablets
CN112206213A (en) Sildenafil citrate composition and preparation method thereof
US5733551A (en) Process for preparing spheroids of plant origin
CN104906160B (en) A kind of enteric coated preparations of erigeron breviscapus extract
CN109432023A (en) A kind of ibuprofen arginine tablet and preparation method thereof
CN106619547A (en) Low-specification meloxicam tablet composition and preparation method thereof
CN104173307A (en) Preparation method of ezetimibe tablet
CN102525976B (en) Method for preparing strontium ranelate orally disintegrating tablets with fluidized bed
CN104606145B (en) ibuprofen granule and preparation method thereof
CN111346064A (en) Rivaroxaban tablet and preparation method thereof
CN110876728A (en) Preparation method of metformin hydrochloride quick-release preparation
CN108968051A (en) Resveratrol sustained release preparation and preparation method thereof
CN105055353B (en) A kind of Entecavir tablet and preparation method thereof
CN103989643A (en) Tablet containing ramelteon and copovidone
CN104510723A (en) Labetalol hydrochloride slow-release capsule and preparation method thereof
CN101856340A (en) The technology of preparing of effervescent pellet

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190308

RJ01 Rejection of invention patent application after publication